View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
October 20, 2017updated 30 Nov 2021 11:39am

Deals this week: Harbin Gloria Pharmaceuticals, F. Hoffmann-La Roche, Intrexon

Chinese pharmaceutical company Harbin Gloria Pharmaceuticals intends to issue medium-term notes due 2019 in a public offering to raise CNY1.6bn ($243.13m).

By Rosanna Jeffery

Chinese pharmaceutical company Harbin Gloria Pharmaceuticals intends to issue medium-term notes due 2019 in a public offering to raise CNY1.6bn ($243.13m).

F. Hoffmann-La Roche (Roche ) and Warp Drive Bio have formed a partnership to deploy the latter’s genome mining platform to develop antibiotics for bacterial infections.

Warp Drive Bio will receive an upfront payment of $87m and up to $300m in milestone payments for sales on products licensed to Roche

Roche is a Switzerland-based pharmaceutical company, while Warp Drive Bio is a drug discovery company based in the US.

“F. Hoffmann-La Roche (Roche ) and Warp Drive Bio have formed a partnership to deploy the latter’s genome mining platform to develop antibiotics for bacterial infections.”

US-based biotechnology company Intrexon plans to raise $100m through the private placement of one million series A redeemable preferred stock priced at $100 a share.

Opiant Pharmaceuticals plans to raise $150m through a public offering of common stock and warrants.

The US-based pharmaceutical company plans to use the funds for general corporate purposes.

Lipocine plans to issue shares of its common stock in a public offering to raise $25m.

The US-based pharmaceutical firm plans to use the funds towards general corporate purposes.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology